F. Pasquier

发表

Temporal order of clinical and biomarker changes in familial frontotemporal dementia

Jennifer M. Nicholas, Sheng-Yang M. Goh, M. Freedman, 2022, Nature Medicine.

Temporal dynamics predict symptom onset and cognitive decline in familial frontotemporal dementia

A. Danek, R. Vandenberghe, T. Rittman, 2022, Alzheimer's & dementia : the journal of the Alzheimer's Association.

Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing

Eden R Martin, Seth Love, Brian Lawlor, 2019, Nature Genetics.

Identification of evolutionarily conserved gene networks mediating neurodegenerative dementia.

Nick C. Fox, Pietro Pietrini, Alexander Gerhard, 2018, Nature Medicine.

Susceptible genes and disease mechanisms identified in frontotemporal dementia and frontotemporal dementia with Amyotrophic Lateral Sclerosis by DNA-methylation and GWAS

E. Haan, P. Pietrini, R. Petersen, 2017, Scientific Reports.

Early neurotransmitters changes in prodromal frontotemporal dementia: A GENFI study

M. Freedman, J. Dukart, R. Keren, 2023, Neurobiology of Disease.

The Benson Complex Figure Test detects deficits in visuoconstruction and visual memory in symptomatic familial frontotemporal dementia: A GENFI study

Y. Pijnenburg, R. Vandenberghe, D. Thomas, 2023, Journal of the Neurological Sciences.

Neuropsychiatric afflictions of modern French Presidents: Maréchal Henri‐Philippe Pétain and Paul Deschanel

F. Lebert, F. Boller, F. Pasquier, 1999, European journal of neurology.

Structural MRI predicts clinical progression in presymptomatic genetic frontotemporal dementia: findings from the GENetic Frontotemporal dementia Initiative cohort

J. E. Iglesias, Jennifer M. Nicholas, M. Freedman, 2023, Brain communications.

A C6orf10/LOC101929163 locus is associated with age of onset in C9orf72 carriers

Nick C Fox, Alan J. Thomas, D. Hernandez, 2018, Brain : a journal of neurology.

Genetic forms of primary progressive aphasia within the GENetic Frontotemporal dementia Initiative (GENFI) cohort: comparison with sporadic primary progressive aphasia

R. Vandenberghe, S. Sorbi, D. Galimberti, 2023, Brain communications.

Prodromal language impairment in genetic frontotemporal dementia within the GENFI cohort

Jennifer M. Nicholas, M. Freedman, R. Keren, 2023, Journal of the Neurological Sciences.

EFNS‐ENS Guidelines on the diagnosis and management of disorders associated with dementia

P. Scheltens, M. Rossor, F. Pasquier, 2012, European journal of neurology.

A New Rating Scale for Age-Related White Matter Changes Applicable to MRI and CT

P. Scheltens, D. Leys, F. Barkhof, 2001, Stroke.

Pronounced impact of Th1/E47cs mutation compared with -491 AT mutation on neural APOE gene expression and risk of developing Alzheimer's disease.

J. Hardy, A. Delacourte, D. Galasko, 1998, Human molecular genetics.

Duration of preclinical, prodromal, and dementia stages of Alzheimer's disease in relation to age, sex, and APOE genotype

A. Sinclair, A. Hout, K. Blennow, 2019, Alzheimer's & Dementia.

An unbiased, staged, multicentre, validation strategy for Alzheimer's disease CSF tau levels

Nick C Fox, P. Scheltens, M. Rossor, 2010, Experimental Neurology.

Common variants at ABCA 7 , MS 4 A 6 A / MS 4 A 4 E , EPHA 1 , CD 33 and CD 2 AP are associated with Alzheimer ’ s disease

Nick C Fox, John X. Morris, Thomas W. Mühleisen, 2011 .

CXCR4 involvement in neurodegenerative diseases

O. Andreassen, G. Schellenberg, A. Dale, 2017, bioRxiv.

APOE and Alzheimer disease: a major gene with semi-dominant inheritance

P. Bosco, P. Deyn, B. Dubois, 2011, Molecular Psychiatry.

Alzheimer risk associated with a copy number variation in the complement receptor 1 increasing C3b/C4b binding sites

F. Pasquier, C. Broeckhoven, K. Sleegers, 2011, Molecular Psychiatry.

The transcriptional factor LBP-1c/CP2/LSF gene on chromosome 12 is a genetic determinant of Alzheimer's disease.

D. Clair, J. Hardy, F. Pasquier, 2000, Human molecular genetics.

Genome-wide haplotype association study identifies the FRMD4A gene as a risk locus for Alzheimer's disease

M Mancuso, R Ferri, P. Bosco, 2012, Molecular Psychiatry.

Protective effects of HLA-DRB1*04 subtypes in Parkinson's and Alzheimer's diseases implicate acetylated Tau PHF6 sequences

Michaël E. Belloy, W. M. van der Flier, D. Rujescu, 2021, medRxiv.

Large meta-analysis of genome-wide association studies expands knowledge of the genetic etiology of Alzheimer disease and highlights potential translational opportunities

Pavel P. Kuksa, D. Rujescu, S. Djurovic, 2020, medRxiv.

Alzheimer disease with cerebrovascular disease and vascular dementia: clinical features and course compared with Alzheimer disease

F. Pasquier, F. Lebert, P. Amouyel, 2008, Journal of Neurology, Neurosurgery, and Psychiatry.

Cognitive Decline and Survival in Alzheimer’s Disease according to Education Level

F. Pasquier, P. Amouyel, S. Bombois, 2007, Dementia and Geriatric Cognitive Disorders.

Genetic variation across RNA metabolism and cell death gene networks is implicated in the semantic variant of primary progressive aphasia

P. Pietrini, R. Desikan, J. Trojanowski, 2019, Scientific Reports.

Apolipoprotein E and Alzheimer disease: genotype-specific risks by age and sex.

Miguel Ángel Martínez, Y Agid, Y. Agid, 1997, American journal of human genetics.

[Clinical diagnosis of frontotemporal dementia].

F. Pasquier, F. Lebert, H. Petit, 1998, Revue neurologique.

Association of 3′-UTR polymorphisms of the oxidised LDL receptor 1 (OLR1) gene with Alzheimer’s disease

S. DeKosky, F. Pasquier, D. Mann, 2003, Journal of medical genetics.

NfL reliability across laboratories, stage-dependent diagnostic performance and matrix comparability in genetic FTD: a large GENFI study.

P. Tiraboschi, R. Laforce, M. Tartaglia, 2024, Journal of neurology, neurosurgery, and psychiatry.

Diagnostic accuracy of research criteria for prodromal frontotemporal dementia

Y. Pijnenburg, T. Rittman, B. Nacmias, 2024, Alzheimer's Research & Therapy.